⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SCTX News
Scribe Therapeutics Inc. Common Stock
Form 8-K
sec.gov
SCTX
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
globenewswire.com
SCTX
Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences
globenewswire.com
SCTX
Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026
globenewswire.com
SCTX
Form 8-K
sec.gov
SCTX
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
globenewswire.com
SCTX
Scribe Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
SCTX
Form 8-K
sec.gov
SCTX
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
globenewswire.com
SCTX